← Evidence map

Observational studyTuberkuloz ve toraks2023

Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life experience with omalizumab.

Dane Ediger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36912406